BRIAN KRUSTCHINSKY: Open Payments
NPI 1952392953 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 19 payments from 9 companies in 2025. Trend: 2023 $137 · 2024 $154 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| PFIZER INC. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| AtriCure, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: LifeVest, JARDIANCE, ELIQUIS, FARXIGA, ONPATTRO, ATRICLIP LAA EXCLUSION SYSTEM, WAINUA, NEXLETOL.
Industry payments across TX — which companies pay providers there.
